Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00742170 · ClinicalTrials.gov registry record · Phase 1
Transdermal Electroacupuncture for Opioid Detoxification
A Phase 1 study of Opioid Dependency, sponsored by Mclean Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT00742170: Completed Phase 1 study of Opioid Dependency, sponsored by Mclean Hospital.
NCT00742170 is a Phase 1 study of Opioid Dependency that has completed, run by Mclean Hospital. The registered enrollment target is 48 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00742170, a Phase 1 study of Opioid Dependency, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-blind, randomized clinical trial tests whether electroacupuncture, provided as an adjunctive treatment, improves outcomes among patients receiving inpatient opioid detoxification from opioids.
Conditions Studied
Interventions
- DEVICE Electroacupuncture
Study Locations (1)
Massachusetts
- McLean Hospital - Belmont
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
What the finished NCT00742170 record still lists
NCT00742170 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (20% lower).
The record links to 1 condition, with Opioid Dependency appearing as the primary indexed condition, and to 1 intervention - of which Electroacupuncture is the first listed.
NCT00742170 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00742170 about?
NCT00742170 is a clinical study titled "Transdermal Electroacupuncture for Opioid Detoxification". This single-blind, randomized clinical trial tests whether electroacupuncture, provided as an adjunctive treatment, improves outcomes among patients receiving inpatient opioid detoxification from opioids.
What is the current status of trial NCT00742170?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2007-08. Estimated completion is 2010-01.
What conditions does trial NCT00742170 study?
This clinical trial studies the following conditions: Opioid Dependency.
What interventions are being tested in trial NCT00742170?
The interventions under investigation include: Electroacupuncture (DEVICE).
Who is sponsoring clinical trial NCT00742170?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00742170 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Dependency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00742170's enrollment target sits among peer trials
48 1025th of 2000 higher than 948 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia